Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Tolerability Trial of Arimoclomol for Sporadic Inclusion Body Myositis

NCT00769860 is registered in ClinicalTrials.gov with Richard Barohn, MD as lead sponsor.

NCT NCT00769860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00769860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Tolerability Trial of Arimoclomol for Sporadic Inclusion Body Myositis
Lead sponsor
Richard Barohn, MD
Phase
Phase 2/3
Overall status
Completed
Start date
September 30, 2008
Completion date
September 30, 2012
Enrollment
24 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

inclusion body myositis